Rothschild & Co Asset Management US’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $45.9M | Sell |
|
|||||
|
2022
Q3 | $26.5M | Sell |
|
|||||
|
2022
Q2 | $35.3M | Buy |
|
|||||
|
2022
Q1 | $44.4M | Buy |
|
|||||
|
2021
Q4 | $28.6M | Sell |
|
|||||
|
2021
Q3 | $29.4M | Sell |
|
|||||
|
2021
Q2 | $26.9M | Sell |
|
|||||
|
2021
Q1 | $39.5M | Sell |
|
|||||
|
2020
Q4 | $44.4M | Sell |
|
|||||
|
2020
Q3 | $57.1M | Sell |
|
|||||
|
2020
Q2 | $49.9M | Sell |
|
|||||
|
2020
Q1 | $42.5M | Sell |
|
|||||
|
2019
Q4 | $61.7M | Sell |
|
|||||
|
2019
Q3 | $51M | Buy |
|
|||||
|
2019
Q2 | $40.8M | Buy |
|
|||||
|
2019
Q1 | $42.7M | Sell |
|
|||||
|
2018
Q4 | $32.5M | Buy |
|
|||||
|
2018
Q3 | $32.3M | Sell |
|
|||||
|
2018
Q2 | $27.8M | Sell |
|
|||||
|
2018
Q1 | $24.1M | Sell |
|
|||||
|
2017
Q4 | $25.5M | Sell |
|
|||||
|
2017
Q3 | $22.9M | Buy |
|
|||||
|
2017
Q2 | $17.5M | Buy |
|
|||||
|
2017
Q1 | $17.9M | Buy |
|
|||||
|
2016
Q4 | $19.4M | Buy |
|
|||||
|
2016
Q3 | $16.6M | Buy |
|
|||||
|
2016
Q2 | $8.52M | Buy |
|
|||||
|
2016
Q1 | $7.12M | Buy |
|
|||||
|
2015
Q4 | $9.15M | Sell |
|
|||||
|
2015
Q3 | $8.56M | Sell |
|
|||||
|
2015
Q2 | $15.8M | Buy |
|